Cybin (HELP) Depreciation and Depletion (2020 - 2023)
Cybin (HELP) reported Depreciation and Depletion of -$56037.0 for Q1 2023, down 1051.88% on a YoY basis from $5887.0 in Q1 2022, and down 1352.5% quarter-over-quarter from $4474.0 in Q2 2022.
Cybin (HELP) Depreciation and Depletion (2020 - 2023) Analysis & Trends
Cybin has reported Depreciation and Depletion for 4 years, with the latest figure at -$56037.0 in Q1 2023.
- For the quarter ending Q1 2023, Depreciation and Depletion fell 1051.88% year-over-year to -$56037.0; the trailing twelve-month figure through Feb 2023 stood at -$10769.2 (down 110.25% YoY), and the FY2023 full-year result was $36915.1, up 125.73% from the prior year.
- Depreciation and Depletion for Q1 2023 stood at -$56037.0, down from $4474.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $34906.8 in Q4 2021, with the low at -$56037.0 in Q1 2023.
- Historically, Depreciation and Depletion has averaged $9068.8 across 4 years, with a median of $9971.7 in 2020.
- Annual changes were most pronounced in 2021 — Depreciation and Depletion surged 250.06% — and 2023, when it slumped 1051.88%.
- Cybin's Depreciation and Depletion stood at $9971.7 in 2020, then surged by 250.06% to $34906.8 in 2021, then sank by 87.18% to $4474.0 in 2022, then plunged by 1352.5% to -$56037.0 in 2023.
- The last three Depreciation and Depletion figures came in at -$56037.0 (Q1 2023), $4474.0 (Q2 2022), and $5887.0 (Q1 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2023 | -56,036.99 |
| Feb 28, 2023 | -56,036.99 |
| May 31, 2022 | 4,474.02 |
| May 31, 2022 | 4,474.02 |
| Feb 28, 2022 | 5,886.99 |
| Feb 28, 2022 | 5,886.99 |
| Dec 31, 2021 | 34,906.79 |
| Dec 31, 2021 | 34,906.79 |
| Sep 30, 2021 | 33,365.19 |
| Sep 30, 2021 | 33,365.19 |
| Jun 30, 2021 | 30,914.03 |
| Jun 30, 2021 | 30,914.03 |
| Dec 31, 2020 | 9,971.71 |
| Dec 31, 2020 | 9,971.71 |